|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
![]() |
![]() |
||||||||||||
![]() |
|||||||||||||
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Will Rosellini, JD, MBA Jordan Curnes, MBA Chief Medical Officer and Senior Vice President of Regulatory Affairs Dr. Rosenfeld joins the company from Bioness Inc, where he was Chief Medical Officer and Vice President of Medical & Regulatory Affairs. He directed all clinical, regulatory, and reimbursement activities for various external and implantable neurostimulation devices. He received his undergraduate degree from Harvard College in the area of Neurobiology, and received his JD from the University of Pennsylvania. After practicing for several years as an FDA regulatory attorney for Hogan & Hartson, LLP in Washington, DC, he received his MD from the Medical College of Virginia. Dr. Rosenfeld completed his residency training at the Rehabilitation Institute of Chicago/Northwestern Memorial Hospital in the specialty of Physical Medicine & Rehabilitation, where he concentrated on the neurorehabilitation of patients with a variety of neurological conditions, including stroke, traumatic brain injury, spinal cord injury, multiple sclerosis, and chronic pain. He has authored numerous peer-reviewed scientific publications, and he is a Fellow of the American College of Legal Medicine. Brent Tarver Vice President of Clinical Affairs Brent brings over 20 years of experience in clinical studies focused on medical devices. Most recently he oversaw the product development and clinical study efforts at OrthoAccel Technologies. Prior to this, Brent worked at Cyberonics for 18 years and helped them grow from a small start-up into a prominent neurostimulation company. Brent received a Bachelor of Science in Electrical Engineering from Rice University and is named on several patents. His areas of expertise include pre-clinical study management, clinical study design and operations, Contract Research Organization (CRO) oversight, regulatory (Investigational Device Exemption [IDE] & Premarket Approval Application [PMA]) submissions, FDA negotiations, FDA panel meeting presentations. While at Cyberonics Mr. Tarver managed the epilepsy development program, culminating in FDA approval in 1997; he later managed the depression studies, PMA submission (2003), and depression panel efforts (2004), which culminated in FDA approval in 2005. Rick Weiner, MD, FACS Chairman of Scientific Advisory Board Dr. Weiner is the former Chair of Neurosurgery at Presbyterian Hospital and co-founder of Dallas Neurological Associates. He is a pioneer in the placement of deep brain and peripheral nerve stimulators. He is a clinical associate professor at UT Southwestern and is actively involved in clinical medical research using neurostimulation to treat a number of neurological disorders including chronic pain, chronic headache, and brain tumors. He has numerous publications in peer reviewed journals and medical textbooks on a variety of clinical issues. Larry Cauller, PhD Co-Founder Dr. Cauller is an Associate Professor of Neuroscience at the University of Texas at Dallas and is the inventor of the platform wireless technology. He has extensive prior experience in device development with DARPA prosthetic projects. He has one issued patent for a wireless neurostimulator. Navzer Engineer, MD, PhD Vice President of Preclinical Affairs Dr. Engineer has worked in the field of neuromodulation and cortical plasticity for the past 10 years. His expertise involves deep brain stimulation, environmental enrichment and discrimination training for stimulating cortical plasticity. He directs preclinical testing for both neurostimulation for pain and vagus nerve stimulation for tinnitus and other neurological indications. Reema Casavant, PhD Vice President of Research Operations Dr. Casavant is a cellular neurophysiologist by training. After receiving her degree, she joined the Naval Health Research Center, EHEL detachment, and served as a researcher and project manager. After a stint at the military research labs, she became a scientific consultant, grant writer, editor, and reviewer before joining MTI. Currently she directs the grants program, interfaces with many of our scientific collaborators, and manages several pre-clinical studies. Chester Burress Director of Technical Operations Chester has 15 years experience in the Class III Medical Device field including 5 years with Sulzer Intermedics, 2 years with Micromed Cardiovascular, and 6 years with Cyberonics. Most recently Chester served as Site Operations Manager and R&D Engineer with Dentsply International - Tulsa Dental Specialties developing Nitinol wire with increased mechanical properties for use in endodontic files. Ravi Jain Director of Mechanical Engineering Ravi spent 3 years leading the development of Class III cardiac pacing leads for the treatment of congestive heart failure at St. Jude Medical. He brings over 7 years of medical device and solar product development experience to the company, including roles in quality assurance, manufacturing, product development, and program management. Ravi received his BSE in Mechanical Engineering and Applied Mechanics from the University of Pennsylvania and a MS in Manufacturing Systems Engineering from Stanford University. David Pierce Director of RF Engineering David currently holds a Master's degree in Electrical Engineering and will complete a PhD in Biomedical Engineering. His past research has included such topics as antennae design for magnetically coupled systems, Bio-MEMS microgrippers for single cell manipulation, and electron mobility in AlGaAs. Mr. Pierce has 8+ years of cleanroom experience in standard MEMS processes. He is a veteran of the US Army serving 4 years overseas. His research includes neural stimulation/recording, energy harvesting, robotics, viticulture and oenology.
|